Cargando…

Independent association between age- and sex-specific metabolic syndrome severity score and cardiovascular disease and mortality

Traditional metabolic syndrome (MetS) criteria have several limitations, which hinder its use in clinical practice. To overcome the limitations, we investigated the association between age- and sex-specific continuous MetS severity score (cMetS-S) and cardiovascular disease (CVD) and mortality beyon...

Descripción completa

Detalles Bibliográficos
Autores principales: Honarvar, Mohammadjavad, Mehran, Ladan, Masoumi, Safdar, Agahi, Sadaf, Khalili, Shayesteh, Azizi, Fereidoun, Amouzegar, Atieh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10480156/
https://www.ncbi.nlm.nih.gov/pubmed/37669997
http://dx.doi.org/10.1038/s41598-023-41546-y
_version_ 1785101729879031808
author Honarvar, Mohammadjavad
Mehran, Ladan
Masoumi, Safdar
Agahi, Sadaf
Khalili, Shayesteh
Azizi, Fereidoun
Amouzegar, Atieh
author_facet Honarvar, Mohammadjavad
Mehran, Ladan
Masoumi, Safdar
Agahi, Sadaf
Khalili, Shayesteh
Azizi, Fereidoun
Amouzegar, Atieh
author_sort Honarvar, Mohammadjavad
collection PubMed
description Traditional metabolic syndrome (MetS) criteria have several limitations, which hinder its use in clinical practice. To overcome the limitations, we investigated the association between age- and sex-specific continuous MetS severity score (cMetS-S) and cardiovascular disease (CVD) and mortality beyond MetS components in the framework of the Tehran Lipid and Glucose Study. Participants aged 20–60 years at baseline were included in the study. We excluded participants with CVD, cancer, use of corticosteroids, estimated glomerular filtration rate < 30 ml/min/1.73 m(2), and those who were pregnant. We evaluated the association between cMetS-S with CVD and mortality over 18 years of follow-up among 8500 participants with continuous and quantile approaches using the Cox proportional hazard regression model. In addition, the model performance of cMetS-S for predicting CVD events was compared to the conventional MetS criteria. Participants with higher cMetS-S had a significantly increased risk for CVD, coronary (CHD) and non-coronary heart disease (non-CHD), and all-cause, cardiovascular, and sudden cardiac death. Independent of the confounders and MetS components, the cMetS-S had the HRs of 1.67 (95% CI 1.47–1.89), 1.60 (95% CI 1.37–1.86), and 1.88 (95% CI 1.50, 2.35) for CVD, CHD, and non-CHD events upon 1-SD increment, respectively. The risk of mortality was increased for 1-SD of cMetS-S (all-cause mortality, HR 1.24; 95% CI 1.09–1.41; CVD mortality, HR 1.72; 95% CI 1.20–2.45; sudden cardiac death, HR 1.60; 95% CI 1.03–2.49). The model fitness of cMetS-S was superior to the conventional MetS criteria in predicting CVD and mortality. The cMetS-S provided an additional risk for CVD and mortality beyond the individual MetS components. Standardized cMetS-S could be a potential universal measure to define MetS severity while considering the weighted contribution of MetS components and their variations by age, sex, and ethnicity.
format Online
Article
Text
id pubmed-10480156
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-104801562023-09-07 Independent association between age- and sex-specific metabolic syndrome severity score and cardiovascular disease and mortality Honarvar, Mohammadjavad Mehran, Ladan Masoumi, Safdar Agahi, Sadaf Khalili, Shayesteh Azizi, Fereidoun Amouzegar, Atieh Sci Rep Article Traditional metabolic syndrome (MetS) criteria have several limitations, which hinder its use in clinical practice. To overcome the limitations, we investigated the association between age- and sex-specific continuous MetS severity score (cMetS-S) and cardiovascular disease (CVD) and mortality beyond MetS components in the framework of the Tehran Lipid and Glucose Study. Participants aged 20–60 years at baseline were included in the study. We excluded participants with CVD, cancer, use of corticosteroids, estimated glomerular filtration rate < 30 ml/min/1.73 m(2), and those who were pregnant. We evaluated the association between cMetS-S with CVD and mortality over 18 years of follow-up among 8500 participants with continuous and quantile approaches using the Cox proportional hazard regression model. In addition, the model performance of cMetS-S for predicting CVD events was compared to the conventional MetS criteria. Participants with higher cMetS-S had a significantly increased risk for CVD, coronary (CHD) and non-coronary heart disease (non-CHD), and all-cause, cardiovascular, and sudden cardiac death. Independent of the confounders and MetS components, the cMetS-S had the HRs of 1.67 (95% CI 1.47–1.89), 1.60 (95% CI 1.37–1.86), and 1.88 (95% CI 1.50, 2.35) for CVD, CHD, and non-CHD events upon 1-SD increment, respectively. The risk of mortality was increased for 1-SD of cMetS-S (all-cause mortality, HR 1.24; 95% CI 1.09–1.41; CVD mortality, HR 1.72; 95% CI 1.20–2.45; sudden cardiac death, HR 1.60; 95% CI 1.03–2.49). The model fitness of cMetS-S was superior to the conventional MetS criteria in predicting CVD and mortality. The cMetS-S provided an additional risk for CVD and mortality beyond the individual MetS components. Standardized cMetS-S could be a potential universal measure to define MetS severity while considering the weighted contribution of MetS components and their variations by age, sex, and ethnicity. Nature Publishing Group UK 2023-09-05 /pmc/articles/PMC10480156/ /pubmed/37669997 http://dx.doi.org/10.1038/s41598-023-41546-y Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Honarvar, Mohammadjavad
Mehran, Ladan
Masoumi, Safdar
Agahi, Sadaf
Khalili, Shayesteh
Azizi, Fereidoun
Amouzegar, Atieh
Independent association between age- and sex-specific metabolic syndrome severity score and cardiovascular disease and mortality
title Independent association between age- and sex-specific metabolic syndrome severity score and cardiovascular disease and mortality
title_full Independent association between age- and sex-specific metabolic syndrome severity score and cardiovascular disease and mortality
title_fullStr Independent association between age- and sex-specific metabolic syndrome severity score and cardiovascular disease and mortality
title_full_unstemmed Independent association between age- and sex-specific metabolic syndrome severity score and cardiovascular disease and mortality
title_short Independent association between age- and sex-specific metabolic syndrome severity score and cardiovascular disease and mortality
title_sort independent association between age- and sex-specific metabolic syndrome severity score and cardiovascular disease and mortality
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10480156/
https://www.ncbi.nlm.nih.gov/pubmed/37669997
http://dx.doi.org/10.1038/s41598-023-41546-y
work_keys_str_mv AT honarvarmohammadjavad independentassociationbetweenageandsexspecificmetabolicsyndromeseverityscoreandcardiovasculardiseaseandmortality
AT mehranladan independentassociationbetweenageandsexspecificmetabolicsyndromeseverityscoreandcardiovasculardiseaseandmortality
AT masoumisafdar independentassociationbetweenageandsexspecificmetabolicsyndromeseverityscoreandcardiovasculardiseaseandmortality
AT agahisadaf independentassociationbetweenageandsexspecificmetabolicsyndromeseverityscoreandcardiovasculardiseaseandmortality
AT khalilishayesteh independentassociationbetweenageandsexspecificmetabolicsyndromeseverityscoreandcardiovasculardiseaseandmortality
AT azizifereidoun independentassociationbetweenageandsexspecificmetabolicsyndromeseverityscoreandcardiovasculardiseaseandmortality
AT amouzegaratieh independentassociationbetweenageandsexspecificmetabolicsyndromeseverityscoreandcardiovasculardiseaseandmortality